IU5
ISO-URSODEOXYCHOLIC ACID
| Created: | 1999-11-10 |
| Last modified: | 2011-06-04 |
Find Related PDB Entry |
|---|
Find related ligands: |
|---|
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 68 |
| Chiral Atom Count | 10 |
| Bond Count | 71 |
| Aromatic Bond Count | 0 |
Chemical Component Summary | |
|---|---|
| Name | ISO-URSODEOXYCHOLIC ACID |
| Systematic Name (OpenEye OEToolkits) | (4R)-4-[(3S,5S,7S,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid |
| Formula | C24 H40 O4 |
| Molecular Weight | 392.572 |
| Type | NON-POLYMER |
Chemical Descriptors | |||
|---|---|---|---|
| Type | Program | Version | Descriptor |
| SMILES | ACDLabs | 10.04 | O=C(O)CCC(C4C3(C(C1C(C2(C(CC1O)CC(O)CC2)C)CC3)CC4)C)C |
| SMILES | CACTVS | 3.341 | C[CH](CCC(O)=O)[CH]1CC[CH]2[CH]3[CH](O)C[CH]4C[CH](O)CC[C]4(C)[CH]3CC[C]12C |
| SMILES | OpenEye OEToolkits | 1.5.0 | CC(CCC(=O)O)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)O)C)O)C |
| Canonical SMILES | CACTVS | 3.341 | C[C@H](CCC(O)=O)[C@H]1CC[C@H]2[C@@H]3[C@@H](O)C[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C |
| Canonical SMILES | OpenEye OEToolkits | 1.5.0 | C[C@H](CCC(=O)O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@@H](C4)O)C)O)C |
| InChI | InChI | 1.03 | InChI=1S/C24H40O4/c1-14(4-7-21(27)28)17-5-6-18-22-19(9-11-24(17,18)3)23(2)10-8-16(25)12-15(23)13-20(22)26/h14-20,22,25-26H,4-13H2,1-3H3,(H,27,28)/t14-,15+,16+,17-,18+,19+,20+,22+,23+,24-/m1/s1 |
| InChIKey | InChI | 1.03 | RUDATBOHQWOJDD-DNMBCGTGSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under aCreative Common's Attribution-NonCommercial 4.0 International License
| DrugBank ID | DB01586 |
|---|---|
| Name | Ursodeoxycholic acid |
| Groups |
|
| Description | Ursodeoxycholic acid (UDCA), also known as ursodiol, is a naturally-occurring bile acid that constitutes a minor fraction of the human bile acid pool.[A256272,A256277] UDCA has been used to treat liver disease for decades: its first use in traditional medicine dates back more than a hundred years.[A256267,A256463] UDCA was first characterized in the bile of the Chinese black bear and is formed by 7b-epimerization of [chenodeoxycholic acid], which is a primary bile acid.[A256272] Due to its hydrophilicity, UDCA is less toxic than [cholic acid] or [chenodeoxycholic acid].[A256272] UDCA was first approved by the FDA in 1987 for dissolution of gallstones and for primary biliary cirrhosis in 1996.[A256272] UDCA works by replacing the hydrophobic or more toxic bile acids from the bile acid pool.[A256272] |
| Synonyms |
|
| Brand Names |
|
| Indication | Ursodeoxycholic acid is indicated for the treatment of patients with primary biliary cholangitis.[L44627] It is used for the short-term treatment of radiolucent, noncalcified gallbladder stones in patients selected for elective cholecystectomy. It is also used to prevent gallstone formation in obese patients experiencing rapid weight loss.[L44793] |
| Categories |
|
| ATC-Code | A05AA02 |
| CAS number | 128-13-2 |
Drug Targets
DrugBank data are sourced from datasets licensed under aCreative Common's Attribution-NonCommercial 4.0 International License
| Name | Target Sequence | Pharmacological Action | Actions |
|---|---|---|---|
| Aldo-keto reductase family 1 member C2 | MDSKYQCVKLNDGHFMPVLGFGTYAPAEVPKSKALEAVKLAIEAGFHHID... | unknown | inhibitor |
| Biliverdin reductase A | MNAEPERKFGVVVVGVGRAGSVRMRDLRNPHPSSAFLNLIGFVSRRELGS... | unknown | activator |
| Solute carrier family 23 member 2 | MMGIGKNTTSKSMEAGSSTEGKYEDEAKHPAFFTLPVVINGGATSSGEQD... | unknown | activator |
| Bile acid receptor | MVMQFQGLENPIQISPHCSCTPSGFFMEMMSMKPAKGVLTEQVAGPLGQN... | unknown | partial agonist |
| Cytochrome P450 3A Subfamily | MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI... | unknown | inducer |
| Bile salt export pump | MSDSVILRSIKKFGEENDGFESDKSYNNDKKSRLQDEKKGDGVRVGFFQL... | unknown | substrate,inhibitor,inducer |
| Solute carrier organic anion transporter family member 1A2 | MGETEKRIETHRIRCLSKLKMFLLAITCAFVSKTLSGSYMNSMLTQIERQ... | unknown | substrate,inhibitor,inducer |
| ATP-binding cassette sub-family C member 2 | MLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGYLWLLAPWQLLH... | unknown | inducer |
| ATP-binding cassette sub-family C member 4 | MLPVYQEVKPNPLQDANLCSRVFFWWLNPLFKIGHKRRLEEDDMYSVLPE... | unknown | inhibitor |
| Ileal sodium/bile acid cotransporter | MNDPNSCVDNATVCSGASCVVPESNFNNILSVVLSTVLTILLALVMFSMG... | unknown | inhibitor |
| Hepatic sodium/bile acid cotransporter | MEAHNASAPFNFTLPPNFGKRPTDLALSVILVFMLFFIMLSLGCTMEFSK... | unknown | substrate,inhibitor |
| Chloride anion exchanger | MIEPFGNQYIVARPVYSTNAFEENHKKTGRHHKTFLDHLKVCCSCSPQKA... | unknown | upregulator |
| View More | |||
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, JewisonT, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
| Resource Name | Reference |
|---|---|
| PubChem | 127601 |
| ChEMBL | CHEMBL1233687 |
| ChEBI | CHEBI:43419 |
| CCDC/CSD | NECPUG |
- RCSB PDB is hosted by
- RCSB PDB is a member of
- RCSB Partners
- Nucleic Acid Knowledgebase
RCSB PDB Core Operations are funded by theU.S. National Science Foundation (DBI-2321666), theUS Department of Energy (DE-SC0019749), and theNational Cancer Institute,National Institute of Allergy and Infectious Diseases, andNational Institute of General Medical Sciences of theNational Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.